Core Laboratories (NYSE:CLB) Price Target Lowered to $15.00 at Stifel Nicolaus

Core Laboratories (NYSE:CLB) had its price objective decreased by Stifel Nicolaus from $19.00 to $15.00 in a research note released on Tuesday,Benzinga reports. Stifel Nicolaus currently has a hold rating on the oil and gas company’s stock.

Separately, Citigroup raised shares of Core Laboratories from a “sell” rating to a “neutral” rating and lifted their price target for the company from $15.00 to $16.00 in a research report on Wednesday, March 12th. One equities research analyst has rated the stock with a sell rating and four have issued a hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $15.75.

Core Laboratories Trading Up 2.1 %

Shares of NYSE:CLB opened at $12.58 on Tuesday. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $587.28 million, a PE ratio of 19.05, a P/E/G ratio of 0.99 and a beta of 1.99. Core Laboratories has a 1 year low of $10.14 and a 1 year high of $25.13. The firm has a fifty day moving average price of $14.63 and a 200 day moving average price of $17.49.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. Analysts expect that Core Laboratories will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date was Monday, February 10th. Core Laboratories’s dividend payout ratio (DPR) is currently 6.06%.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CLB. Assetmark Inc. acquired a new stake in shares of Core Laboratories in the fourth quarter worth $26,000. Smartleaf Asset Management LLC boosted its holdings in Core Laboratories by 173.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock valued at $35,000 after purchasing an additional 1,293 shares during the period. Nisa Investment Advisors LLC grew its position in Core Laboratories by 2,688.5% in the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock worth $42,000 after purchasing an additional 2,339 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Core Laboratories by 843.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company’s stock worth $57,000 after purchasing an additional 2,936 shares during the period. Finally, BNP Paribas Financial Markets acquired a new position in shares of Core Laboratories during the fourth quarter valued at about $123,000. 97.81% of the stock is owned by institutional investors.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.